Evidence for the expression of a second CD6 ligand by synovial fibroblasts

Arthritis and Rheumatism

Volumn 43, Issue 2, 2000, Pages 329-335

  Joo, Yeong Shil ^a   Singer, Nora G ^b   Endres, Judith L ^c   Sarkar, Sujata ^c   Kinne, Raimund W ^c   Marks, Rory M ^d   Fox, David A ^d,e  

^a Eulji University School of Medicine   (South Korea)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD6 ANTIGEN; GAMMA INTERFERON; HYBRID PROTEIN; SUPERANTIGEN;

ARTICLE; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; CYTOKINES; FIBROBLASTS; HUMANS; SUPERANTIGENS; SYNOVIAL MEMBRANE;

EID: 0034043370     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200002)43:2<329::AID-ANR12>3.0.CO;2-Y     Document Type: Article

References (27)

1. Reiter C. Cluster report: CD6. In: Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, et al, editors. Leucocyte typing IV: white cell differentiation antigens. New York: Oxford University Press; 1989. p. 339.
2. Reinherz EL, Meuer S, Fitzgerald KA, Hussey RE, Levine H, Schlossman SF. Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex. Cell 1982;30:735-43.
3. Morimoto C, Rudd CE, Letvin NL, Hagan M, Schlossman SF. 2H1: a novel antigen involved in T lymphocyte triggering. J Immunol 1988;140:2165-70.
4. Gangemi RM, Swack JA, Gaviria DM, Romain PL. Anti-T-12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes. J Immunol 1989;143:2439-47.
5. Bott CM, Dosh JB, Morimoto C, Romain PL, Fox DA. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein. Int Immunol 1993;7:783-92.
6. Osorio LM, Garcia CA, Jondal M, Chow SC. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation. Cell Immunol 1994;154:123-33.
7. Singer NG, Richardson BC, Powers D, Hooper F, Lialios F, Endres J, et al. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 1996;88:537-43.
8. Patel DD, Wee SF, Whichard LP, Bowen MA, Pesando JM, Aruffo A, et al. Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells. J Exp Med 1995;181:1563-8.
9. Wee SF, Wang WC, Farr AG, Nelson AJ, Patel DD, Haynes BF, et al. Characterization of a CD6 ligand expressed on human and murine derived cell lines and murine lymphoid tissues. Cell Immunol 1995;158:353-65.
10. Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, et al. Prevention of graft versus-host-disease by selective depletion of CD6 positive T lymphocytes from donor bone marrow. J Clin Oncol 1992;10:1191-200.
11. Soiffer RJ, Fairclough D, Robertson MJ, Alyea E, Anderson KC, Freedman AS, et al. CD6-depleted bone marrow transplantation for acute leukemia in first complete remission. Blood 1997;89: 3039-47.
12. Rasmussen RA, Counts SL, Daley JF, Schlossman SF. Isolation and characterization of CD6(-) T cells from peripheral blood. J Immunol 1994;152:527-36.
13. Bowen MA, Patel DD, Li X, Modrell B, Malacko AR, Wang W-C, et al. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 1995;181:2213-20.
14. Levesque MC, Heinly CS, Whichard LP, Patel DD. Cytokine-regulated expression of activated leukocyte cell adhesion molecule (CD166) on monocyte-lineage cells and in rheumatoid arthritis synovium. Arthritis Rheum 1998;41:2221-9.
15. Singer NG, Mitra R, Lialios F, Richardson BC, Marks RM, Pesando JM, et al. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on γ-IFN activated keratinocytes. Immunol Lett 1997;58:9-14.
16. Tsai C, Diaz LA Jr, Singer NG, Li LL, Kirsch AH, Mitra R, et al. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1996;39:125-36.
17. Xi H, Marks RM. Use of receptors immobilized on microspheres to identify ligand binding sites in tissue sections: detection of lymph node ligands for L-selectin. Histochem Cell Biol 1997;107: 57-64.
18. Bott CM, Doshi JB, Li LL, McMurtry SA, Sanders JL, Fox DA. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester. J Immunol 1994;153:1-9.
19. Wee SF, Schieven GL, Kirihara JM, Tsu TT, Lebetter JA, Aruffo A. Tyrosine phosphorylation of CD6 by stimulation of CD3: augmentation by the CD4 and CD2 co-receptors. J Exp Med 1993;177:219-23.
20. Pourqui O, Corbel C, Le Caer JP, Rossier J, Le Douarin NM. BEN, a surface glycoprotein of the immunoglobulin super family, is expressed in a variety of developing systems. Proc Natl Acad Sci U S A 1992;89:5261-5.
21. Starling GC, Whitney GS, Siadak AW, Llewellyn MC, Bowen MA, Farr AG. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed lymphocyte reaction. Eur J Immunol 1996;26:738-46.
22. Whitney GS, Starling GC, Bowen MA, Modrell B, Siadak AW, Aruffo A. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site. J Biol Chem 1995;270:18187-90.
23. Griffiths CEM, Voorhees JJ, Nickoloff BJ. γ-interferon induces different keratinocyte cellular patterns of expression of HLA-DR and DQ and intercellular adhesion molecule-1 (ICAM-1) antigens. Br J Dermatol 1989;120:1-8.
24. Johnson BA, Haines GK, Harlow LA, Koch AE. Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993;36:137-46.
25. Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, et al. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia: their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum 1994;37:221-31.
26. Katsikis P, Chu CQ, Brennan FM, Maini RN, Feldman M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
27. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995;38:96-104.